Works by Enokida, Hideki

Results: 95
    1
    2
    3

    The role of microRNAs in bladder cancer.

    Published in:
    Investigative & Clinical Urology, 2016, v. 57, p. S60, doi. 10.4111/icu.2016.57.S1.S60
    By:
    • Hideki Enokida;
    • Hirofumi Yoshino;
    • Ryosuke Matsushita;
    • Masayuki Nakagawa
    Publication type:
    Article
    4

    Real-world treatment outcomes of patients with penile cancer in the Kyushu–Okinawa area of Japan in the pre-guideline era.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 9, p. 837, doi. 10.1093/jjco/hyad053
    By:
    • Yamaguchi, Takahiro;
    • Goya, Masato;
    • Higashijima, Katsuyoshi;
    • Tobu, Shohei;
    • Sato, Ryuta;
    • Tatarano, Shuichi;
    • Mukai, Shoichiro;
    • Uemura, Kei-ichiro;
    • Tatsugami, Katsunori;
    • Tsubouchi, Kazuna;
    • Shida, Yohei;
    • Ishii, Tatsu;
    • Sakai, Hideki;
    • Matsuoka, Hirofumi;
    • Haga, Nobuhiro;
    • Eto, Masatoshi;
    • Igawa, Tsukasa;
    • Kamoto, Toshiyuki;
    • Enokida, Hideki;
    • Shin, Toshitaka
    Publication type:
    Article
    5

    Erratum to: Oncological outcome of neoadjuvant low-dose estramustine plus LHRH agonist/antagonist followed by extended radical prostatectomy for Japanese patients with high-risk localized prostate cancer: a prospective single-arm study.

    Published in:
    Japanese Journal of Clinical Oncology, 2020, v. 50, n. 12, p. 1484, doi. 10.1093/jjco/hyaa227
    By:
    • Enokida, Hideki;
    • Yamada, Yasutoshi;
    • Tatarano, Shuichi;
    • Yoshino, Hirofumi;
    • Yonemori, Masaya;
    • Sakaguchi, Takashi;
    • Nishimura, Hiroaki;
    • Eura, Rumiko;
    • Nakagawa, Masayuki
    Publication type:
    Article
    6

    Oncological outcome of neoadjuvant low-dose estramustine plus LHRH agonist/antagonist followed by extended radical prostatectomy for Japanese patients with high-risk localized prostate cancer: a prospective single-arm study.

    Published in:
    Japanese Journal of Clinical Oncology, 2020, v. 50, n. 1, p. 66, doi. 10.1093/jjco/hyz138
    By:
    • Enokida, Hideki;
    • Yamada, Yasutoshi;
    • Tatarano, Shuichi;
    • Yoshino, Hirofumi;
    • Yonemori, Masaya;
    • Sakaguchi, Takashi;
    • Nishimura, Hiroaki;
    • Eura, Rumiko;
    • Nakagawa, Masayuki
    Publication type:
    Article
    7

    Enzalutamide versus Abiraterone Plus Prednisolone for Nonmetastatic Castration-Resistant Prostate Cancer: A Sub-Analysis from the ENABLE Study for PCa.

    Published in:
    Cancers, 2024, v. 16, n. 3, p. 508, doi. 10.3390/cancers16030508
    By:
    • Mita, Koji;
    • Izumi, Kouji;
    • Goriki, Akihiro;
    • Tasaka, Ryo;
    • Hatayama, Tomoya;
    • Shima, Takashi;
    • Kato, Yuki;
    • Kamiyama, Manabu;
    • Inoue, Shogo;
    • Tanaka, Nobumichi;
    • Hoshi, Seiji;
    • Okamura, Takehiko;
    • Yoshio, Yuko;
    • Enokida, Hideki;
    • Chikazawa, Ippei;
    • Kawai, Noriyasu;
    • Hashimoto, Kohei;
    • Fukagai, Takashi;
    • Shigehara, Kazuyoshi;
    • Takahara, Shizuko
    Publication type:
    Article
    8

    Laparoscopic Surgery for Pheochromocytoma in Hemodialysis Patients.

    Published in:
    International Journal of Nephrology, 2022, p. 1, doi. 10.1155/2022/3060647
    By:
    • Tatarano, Shuichi;
    • Mitsuke, Akihiko;
    • Sakaguchi, Takashi;
    • Matsushita, Ryosuke;
    • Inoguchi, Satoru;
    • Yoshino, Hirofumi;
    • Nishimura, Hiroaki;
    • Yamada, Yasutoshi;
    • Enokida, Hideki
    Publication type:
    Article
    9

    Low dose tacrolimus exposure and early steroid withdrawal with strict body weight control can improve post kidney transplant glucose tolerance in Japanese patients.

    Published in:
    PLoS ONE, 2023, v. 18, n. 10, p. 1, doi. 10.1371/journal.pone.0287059
    By:
    • Mitsuke, Akihiko;
    • Ohbo, Takahiko;
    • Arima, Junya;
    • Osako, Yoichi;
    • Sakaguchi, Takashi;
    • Matsushita, Ryosuke;
    • Yoshino, Hirofumi;
    • Tatarano, Shuichi;
    • Yamada, Yasutoshi;
    • Sasaki, Hajime;
    • Tanabe, Tatsu;
    • Fukuzawa, Nobuyuki;
    • Tanaka, Hiroshi;
    • Nishio, Yoshihiko;
    • Hideki, Enokida;
    • Harada, Hiroshi
    Publication type:
    Article
    10

    Targeting metabolic reprogramming to overcome drug resistance in advanced bladder cancer: insights from gemcitabine‐ and cisplatin‐resistant models.

    Published in:
    Molecular Oncology, 2024, v. 18, n. 9, p. 2196, doi. 10.1002/1878-0261.13684
    By:
    • Kawahara, Ichiro;
    • Yoshino, Hirofumi;
    • Fukumoto, Wataru;
    • Arima, Junya;
    • Saito, Saeki;
    • Li, Gang;
    • Fukuda, Ikumi;
    • Mitsuke, Akihiko;
    • Sakaguchi, Takashi;
    • Inoguchi, Satoru;
    • Matsushita, Ryosuke;
    • Nakagawa, Masayuki;
    • Tatarano, Shuichi;
    • Yamada, Yasutoshi;
    • Enokida, Hideki
    Publication type:
    Article
    11
    12
    13
    14
    15
    16

    Clinicopathological characteristics of adrenocortical carcinoma in the Kyushu–Okinawa area of Japan.

    Published in:
    International Journal of Urology, 2024, v. 31, n. 5, p. 484, doi. 10.1111/iju.15386
    By:
    • Nakanishi, Shotaro;
    • Fukushima, Yumi;
    • Inokuchi, Junichi;
    • Hakariya, Tomoaki;
    • Kakinoki, Hiroaki;
    • Enokida, Hideki;
    • Chikui, Katsuaki;
    • Matsuoka, Hirofumi;
    • Shin, Toshitaka;
    • Mukai, Shoichiro;
    • Kamba, Tomomi;
    • Eto, Masatoshi;
    • Imamura, Ryoichi;
    • Noguchi, Mitsuru;
    • Igawa, Tsukasa;
    • Haga, Nobuhiro;
    • Kamoto, Toshiyuki;
    • Fujimoto, Naohiro;
    • Saito, Seiichi
    Publication type:
    Article
    17

    GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone‐sensitive prostate cancer; KYUCOG‐1401.

    Published in:
    International Journal of Urology, 2024, v. 31, n. 4, p. 362, doi. 10.1111/iju.15371
    By:
    • Yokomizo, Akira;
    • Shiota, Masaki;
    • Morokuma, Futoshi;
    • Eto, Masatoshi;
    • Matsuyama, Hideyasu;
    • Matsumoto, Hiroaki;
    • Kamoto, Toshiyuki;
    • Terada, Naoki;
    • Kawahara, Kazuya;
    • Enokida, Hideki;
    • Tatarano, Shuichi;
    • Fujimoto, Naohiro;
    • Higasijima, Katsuyoshi;
    • Sakai, Hideki;
    • Hakariya, Tomoaki;
    • Igawa, Tsukasa;
    • Suekane, Shigetaka;
    • Kamba, Tomomi;
    • Sugiyama, Yutaka;
    • Kishimoto, Junji
    Publication type:
    Article
    18

    Summary of the Clinical Practice Guidelines for Upper Tract Urothelial Carcinoma 2023 by the Japanese Urological Association.

    Published in:
    International Journal of Urology, 2024, v. 31, n. 3, p. 194, doi. 10.1111/iju.15362
    By:
    • Mori, Kazuyuki;
    • Hatakeyama, Shingo;
    • Enokida, Hideki;
    • Miyake, Hideaki;
    • Kikuchi, Eiji;
    • Nishiyama, Hiroyuki;
    • Ichikawa, Tomohiko;
    • Kamai, Takao;
    • Kaji, Yasushi;
    • Kume, Haruki;
    • Kondo, Tsunenori;
    • Matsuyama, Hideyasu;
    • Masumori, Naoya;
    • Kawauchi, Akihiro;
    • Takenaka, Atsushi;
    • Uemura, Hirotsugu;
    • Eto, Masatoshi;
    • Nonomura, Norio;
    • Fujii, Yasuhisa;
    • Hinotsu, Shiro
    Publication type:
    Article
    19

    Validation of the risk stratification newly defined in the Japanese Urological Association guidelines 2019 for non‐muscle invasive bladder cancer: A multi‐institutional collaborative study.

    Published in:
    International Journal of Urology, 2023, v. 30, n. 5, p. 473, doi. 10.1111/iju.15162
    By:
    • Miyamoto, Tatsuki;
    • Miyake, Makito;
    • Nakahama, Tomonori;
    • Nishimura, Nobutaka;
    • Onishi, Kenta;
    • Iida, Kouta;
    • Yonemori, Masaya;
    • Enokida, Hideki;
    • Nakagawa, Masayuki;
    • Matsumoto, Hiroaki;
    • Matsuyama, Hideyasu;
    • Matsushita, Yuto;
    • Miyake, Hideaki;
    • Fujii, Tomomi;
    • Shimada, Keiji;
    • Baba, Satoshi;
    • Kinjyo, Mitsuru;
    • Shimokama, Tatsuro;
    • Okumura, Koji;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    20

    Efficacy of combined androgen blockade therapy in patients with metastatic hormone‐sensitive prostate cancer stratified by tumor burden.

    Published in:
    International Journal of Urology, 2022, v. 29, n. 5, p. 398, doi. 10.1111/iju.14793
    By:
    • Nagumo, Yoshiyuki;
    • Onozawa, Mizuki;
    • Kojima, Takahiro;
    • Terada, Naoki;
    • Shiota, Masaki;
    • Mitsuzuka, Koji;
    • Yasumoto, Hiroaki;
    • Matsumoto, Hiroaki;
    • Enokida, Hideki;
    • Sugiyama, Takayuki;
    • Kuroiwa, Kentaro;
    • Saito, Toshihiro;
    • Yokomizo, Akira;
    • Kohei, Naoki;
    • Tabata, Ken‐ichi;
    • Takahashi, Atsushi;
    • Sugimoto, Mikio;
    • Kitamura, Hiroshi;
    • Kamoto, Toshiyuki;
    • Nishiyama, Hiroyuki
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    A new risk stratification model for intravesical recurrence, disease progression, and cancer-specific death in patients with non-muscle invasive bladder cancer: the J-NICE risk tables.

    Published in:
    International Journal of Clinical Oncology, 2020, v. 25, n. 7, p. 1364, doi. 10.1007/s10147-020-01654-5
    By:
    • Miyake, Makito;
    • Matsuyama, Hideyasu;
    • Teramukai, Satoshi;
    • Kinoshita, Fumie;
    • Yokota, Isao;
    • Matsumoto, Hiroaki;
    • Shimada, Keiji;
    • Kinjyo, Mitsuru;
    • Shimokama, Tatsuro;
    • Okumura, Koji;
    • Yomenori, Masaya;
    • Enokida, Hideki;
    • Nakagawa, Masayuki;
    • Nakai, Yasushi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    32

    Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients: a subgroup analysis of the phase 3 KEYNOTE-045 trial.

    Published in:
    International Journal of Clinical Oncology, 2020, v. 25, n. 1, p. 165, doi. 10.1007/s10147-019-01545-4
    By:
    • Nishiyama, Hiroyuki;
    • Yamamoto, Yoshiaki;
    • Sassa, Naoto;
    • Nishimura, Kazuo;
    • Fujimoto, Kiyohide;
    • Fukasawa, Satoshi;
    • Yokoyama, Minato;
    • Enokida, Hideki;
    • Takahashi, Kenichi;
    • Tanaka, Yoshinobu;
    • Imai, Kentaro;
    • Shimamoto, Takashi;
    • Perini, Rodolfo;
    • Frenkl, Tara;
    • Bajorin, Dean;
    • Bellmunt, Joaquim
    Publication type:
    Article
    33

    Epigenetics in bladder cancer.

    Published in:
    International Journal of Clinical Oncology, 2008, v. 13, n. 4, p. 298, doi. 10.1007/s10147-008-0811-1
    By:
    • Enokida, Hideki;
    • Nakagawa, Masayuki
    Publication type:
    Article
    34

    Tumor-suppressive microRNA-223 targets WDR62 directly in bladder cancer.

    Published in:
    International Journal of Oncology, 2019, v. 54, n. 6, p. 2222, doi. 10.3892/ijo.2019.4762
    By:
    • Sugita, Satoshi;
    • Yoshino, Hirofumi;
    • Yonemori, Masaya;
    • Miyamoto, Kazutaka;
    • Matsushita, Ryosuke;
    • Sakaguchi, Takashi;
    • Itesako, Toshihiko;
    • Tatarano, Shuichi;
    • Nakagawa, Masayuki;
    • Enokida, Hideki
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Association Study of a Functional Variant on ABCG2 Gene with Sunitinib-Induced Severe Adverse Drug Reaction.

    Published in:
    PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0148177
    By:
    • Low, Siew-Kee;
    • Fukunaga, Koya;
    • Takahashi, Atsushi;
    • Matsuda, Koichi;
    • Hongo, Fumiya;
    • Nakanishi, Hiroyuki;
    • Kitamura, Hiroshi;
    • Inoue, Takamitsu;
    • Kato, Yoichiro;
    • Tomita, Yoshihiko;
    • Fukasawa, Satoshi;
    • Tanaka, Tomoaki;
    • Nishimura, Kazuo;
    • Uemura, Hirotsugu;
    • Hara, Isao;
    • Fujisawa, Masato;
    • Matsuyama, Hideyasu;
    • Hashine, Katsuyoshi;
    • Tatsugami, Katsunori;
    • Enokida, Hideki
    Publication type:
    Article
    46
    47
    48
    49
    50